This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Amgen Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovations of Hongyu Wang
Introduction
Hongyu Wang is a notable inventor based in Coquitlam, Canada. He has made significant contributions to the field of biotechnology, particularly in the development of innovative therapeutic strategies.
Latest Patents
Hongyu Wang holds a patent for the "Combination of LILRB1/2 Pathway Inhibitors and PD-1 Pathway Inhibitors." This patent represents a crucial advancement in cancer treatment, aiming to enhance the efficacy of immunotherapy.
Career Highlights
Wang is currently employed at Amgen Inc., a leading biotechnology company known for its focus on innovative medicines. His work at Amgen has allowed him to contribute to groundbreaking research and development in the field.
Collaborations
He collaborates with talented colleagues, including Xin Yu and Wenjun Ouyang, to further advance their research initiatives and explore new therapeutic avenues.
Conclusion
Hongyu Wang's contributions to biotechnology and his innovative patent highlight his role as a key figure in the ongoing quest for effective cancer therapies. His work continues to inspire advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile